Afuco™ Anti-PA ADCC Recombinant Antibody, ADCC Enhanced (AFC-TAB-440CQ) (CAT#: AFC-TAB-440CQ)
This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant monoclonal antibody to PA. It is a chimeric (mouse/human) monoclonal antibody that can be potentially used in the treatment of Anthrax inhalation.
Specific Inquiry
Specifications
- Immunogen
- The details of the immunogen for this antibody are not available.
- Host Species
- Human
- Derivation
- Chimeric (mouse/human)
- Type
- ADCC enhanced antibody
- Specificity
- Bacillus anthracis anthraxtoxin protective antigen (PA)
- Species Reactivity
- Bacillus anthracis
- Applications
- ELISA, IHC, FC, IP, IF, FuncS
- Conjugate
- Unconjugated
- Generic Name
- Obiltoxaximab
- Related Disease
- Anthrax inhalation
Product Property
- Purity
- >95% by SDS-PAGE
- Storage
- Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.
Target
- Alternative Names
- PA; Bacillus anthracis anthraxtoxin protective antigen
Related Resources
Please refer to Obiltoxaximab Overview to learn more about the mechanism of action, clinical projects, and approved drugs of Obiltoxaximab.
Product Notes
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Downloads
Download resources about recombinant antibody development and antibody engineering to boost your research.
See other products for "Obiltoxaximab"
DrugMonitor™ Anti-Obiltoxaximab Antibody (VS-1224-YC827)Obiltoxaximab is a monoclonal antibody used for the prophylaxis or treatment of inhalational anthrax. The DrugMonitor™ Anti-Obiltoxaximab Antibody (VS-1224-YC827) is an anti-drug antibody (ADA) against Obiltoxaximab. This drug-based antibody is raised in mice immunized with the Obiltoxaximab. The anti-Obiltoxaximab antibody may be used in ELISA, pharmacokinetics (PK), and pharmacodynamics (PD) analyses, or serves as a reference standard in ADA assays. It also is an excellent tool for therapeutic drug monitoring, allowing to evaluate the drug efficacy and determine the drug concentration of the Obiltoxaximab in samples.
See other products for "B. anthracis PA"
Select a product category from the dropdown menu below to view related products.
Please select product type
Single Domain Antibody Products
IgG Antibody Products
Fab Antibody Products
ScFv Antibody Products
Human Antibody Products
Epitope-Specific Antibody Products
ADCC Enhanced Antibody Products
| CAT | Product Name | Application | Type |
|---|---|---|---|
| NAB-194-VHH | Recombinant Anti-B. anthracis PA VHH Single Domain Antibody | WB, ICC, ChiP, FA, ELISA | Llama VHH |
Customer Reviews and Q&As
There are currently no Customer reviews or questions for AFC-TAB-440CQ. Click the button above to contact us or submit your feedback about this product.
Popular products with customers
Application: IF, IP, Neut, FuncS, ELISA, FC, ICC
Application: FC, IP, ELISA, Neut, FuncS, IF, ICC
Application: Neut, ELISA, IF, IP, FuncS, FC, ICC
Application: FC, IP, ELISA, Neut, FuncS, IF, IHC
Application: ELISA, Neut, FuncS
Application: Neut, ELISA, Inhib, ICC, WB
Application: FC, IHC-Fr, IP, ELISA, Block
Application: FC, IA, IF, IP, IHC, FuncS
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
Send Inquiry
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
